Actively Recruiting
Chongqing Diabetes Registry Study
Led by Chongqing Medical University · Updated on 2023-09-06
5000
Participants Needed
1
Research Sites
626 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To investigate the risk factors and biomarkers of the microvascular disease，macrovascular disease and neuropathy in patients with diabetes.
CONDITIONS
Official Title
Chongqing Diabetes Registry Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of diabetes mellitus based on the 1999 WHO diagnostic criteria
- Age younger than 75 years old
- Gender is not limited
- Voluntary signing of informed consent
You will not qualify if you...
- Pregnant or breastfeeding women
- Patients requiring long-term glucocorticoid therapy for chronic diseases
- Patients with severe infection (except diabetic foot) or immune dysfunction
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Qifu Li
Chongqing, Chongqing Municipality, China, 400016
Actively Recruiting
Research Team
Q
Qifu Li, phD
CONTACT
Z
Zhihong Wang, phD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here